13 December 2016

GSK Opens Global Vaccine Center in Rockville, USA

GlaxoSmithKline (GSK) today will officially open its newest global vaccines R&D center in Rockville, MD, where the pharma giant will base 450 researchers and support staffers and spend $50 million over the next 2 years on technology and equipment. The new center—GSK’s first dedicated vaccine R&D facility in the U.S.—will house 12 vaccine development programs, including projects supporting its candidate shingles vaccine, for which GSK applied for FDA approval in October. Source: GEN 13/12/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).